Cargando…
Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828990/ https://www.ncbi.nlm.nih.gov/pubmed/27127464 http://dx.doi.org/10.4103/1673-5374.179038 |
| _version_ | 1782426684073443328 |
|---|---|
| author | Zeynalov, Emil Jones, Susan M. |
| author_facet | Zeynalov, Emil Jones, Susan M. |
| author_sort | Zeynalov, Emil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4828990 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-48289902016-04-28 Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke Zeynalov, Emil Jones, Susan M. Neural Regen Res Perspective Medknow Publications & Media Pvt Ltd 2016-03 /pmc/articles/PMC4828990/ /pubmed/27127464 http://dx.doi.org/10.4103/1673-5374.179038 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Perspective Zeynalov, Emil Jones, Susan M. Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title | Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title_full | Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title_fullStr | Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title_full_unstemmed | Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title_short | Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke |
| title_sort | recent advances and future directions in preclinical research of arginine-vasopressin (avp) receptor blocker conivaptan in the context of stroke |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828990/ https://www.ncbi.nlm.nih.gov/pubmed/27127464 http://dx.doi.org/10.4103/1673-5374.179038 |
| work_keys_str_mv | AT zeynalovemil recentadvancesandfuturedirectionsinpreclinicalresearchofargininevasopressinavpreceptorblockerconivaptaninthecontextofstroke AT jonessusanm recentadvancesandfuturedirectionsinpreclinicalresearchofargininevasopressinavpreceptorblockerconivaptaninthecontextofstroke |